Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Masashi Funauchi"'
Autor:
Yoshikazu Nagase, Kosuke Hiramatsu, Masashi Funauchi, Mayu Shiomi, Tatsuo Masuda, Mamoru Kakuda, Satoshi Nakagawa, Ai Miyoshi, Shinya Matsuzaki, Eiji Kobayashi, Toshihiro Kimura, Satoshi Serada, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Endometrial cancer (EC) is a common gynecologic malignancy and patients with advanced and recurrent EC have a poor prognosis. Although chemotherapy is administered for those patients, the efficacy of current chemotherapy is limite
Externí odkaz:
https://doaj.org/article/2b03d3103a2647edbde2abb81acc9041
Autor:
Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Satoshi Nakagawa, Tomoharu Ohkawara, Okinori Murata, Minoru Fujimoto, Fumiko Chiwaki, Hiroki Sasaki, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 35, Iss , Pp 100853- (2023)
Background: Epithelial ovarian cancer (EOC) is a lethal malignant tumor, for which new treatment options are urgently required. Lipolysis-stimulated lipoprotein receptor (LSR) is widely expressed in EOC, and it is associated with poor prognosis. In t
Externí odkaz:
https://doaj.org/article/8aca4d3343e645dd80e48e4e7a9fbf33
Autor:
Hitomi Sakaguchi, Kosuke Hiramatsu, Yoshikazu Nagase, Masashi Funauchi, Mamoru Kakuda, Satoshi Nakagawa, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3beb3db3b3a0d40e1b8d7f49c063461
https://doi.org/10.1136/ijgc-2022-igcs.374
https://doi.org/10.1136/ijgc-2022-igcs.374
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4861f17de21187dcc6381163e17f04c
https://doi.org/10.1136/ijgc-2022-igcs.100
https://doi.org/10.1136/ijgc-2022-igcs.100
Autor:
Hitomi Sakaguchi, Kosuke Hiramatsu, Yoshikazu Nagase, Masashi Funauchi, Kakuda Mamoru, Satoshi Nakagawa, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::175791a5c6a49cb7b53d15887ceac893
https://doi.org/10.1136/ijgc-2022-esgo.623
https://doi.org/10.1136/ijgc-2022-esgo.623
Autor:
Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Satoshi Nakagawa, Tomoharu Ohkawara, Okinori Murata, Minoru Fujimoto, Fumiko Chiwaki, Hiroki Sasaki, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
Publikováno v:
Neoplasia (New York, N.Y.). 35
Epithelial ovarian cancer (EOC) is a lethal malignant tumor, for which new treatment options are urgently required. Lipolysis-stimulated lipoprotein receptor (LSR) is widely expressed in EOC, and it is associated with poor prognosis. In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8943d9201625254972ff7b2259fd5d55
https://pubmed.ncbi.nlm.nih.gov/36413881
https://pubmed.ncbi.nlm.nih.gov/36413881
Publikováno v:
Cancer Research. 81:1211-1211
Objectives : Previously, we demonstrated anti-cancer effect of our newly developed monoclonal antibody (mAb) targeting lipolysis-stimulated lipoprotein receptor (LSR) in LSR-positive epithelial ovarian cancer (EOC) in vitro and in vivo. In EOC treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caeefd59e81153bdf1b631abe49d13e5
https://doi.org/10.1158/1538-7445.am2021-1211
https://doi.org/10.1158/1538-7445.am2021-1211